Atypical antipsychotic drugs improve cognition in schizophrenia

被引：27

作者：

Meltzer, HY

Sumiyoshi, T

机构：

[1] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA

[2] Toyama Med & Pharmaceut Univ, Dept Neuropsychiat, Toyama, Japan

来源：

BIOLOGICAL PSYCHIATRY | 2003年 / 53卷 / 03期

关键词：

D O I：

10.1016/S0006-3223(02)01790-0

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：265 / 267

页数：3

共 31 条

[1] THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE [J].

BUCHANAN, RW ;

HOLSTEIN, C ;

BREIER, A .

BIOLOGICAL PSYCHIATRY, 1994, 36 (11) :717-725

[2] Another view of therapy for cognition in schizophrenia [J].

Carpenter, WT ;

Gold, JM .

BIOLOGICAL PSYCHIATRY, 2002, 51 (12) :969-971

[3] NEUROLEPTICS - EFFECTS ON NEUROPSYCHOLOGICAL FUNCTION IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].

CASSENS, G ;

INGLIS, AK ;

APPELBAUM, PS ;

GUTHEIL, TG .

SCHIZOPHRENIA BULLETIN, 1990, 16 (03) :477-499

[4] Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study [J].

Cuesta, MJ ;

Peralta, V ;

Zarzuela, A .

SCHIZOPHRENIA RESEARCH, 2001, 48 (01) :17-28

[5] Placebo-controlled trial of glycine added to clozapine in schizophrenia [J].

Evins, AE ;

Fitzgerald, SM ;

Wine, L ;

Rosselli, R ;

Goff, DC .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05) :826-828

[6] Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine [J].

Galletly, CA ;

Clark, CR ;

McFarlane, AC ;

Weber, DL .

PSYCHIATRY RESEARCH, 1997, 72 (03) :161-166

[7] Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review [J].

Geyer, MA ;

Krebs-Thomson, K ;

Braff, DL ;

Swerdlow, NR .

PSYCHOPHARMACOLOGY, 2001, 156 (2-3) :117-154

[8] A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia [J].

Goff, DC ;

Tsai, G ;

Levitt, J ;

Amico, E ;

Manoach, D ;

Schoenfeld, DA ;

Hayden, DL ;

McCarley, R ;

Coyle, JT .

ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (01) :21-27

[9]

Grace J, 1996, PSYCHIATR SERV, V47, P41

[10] The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone [J].

Green, MF ;

Marder, SR ;

Glynn, SM ;

McGurk, SR ;

Wirshing, WC ;

Wirshing, DA ;

Liberman, RP ;

Mintz, J .

BIOLOGICAL PSYCHIATRY, 2002, 51 (12) :972-978

← 1 2 3 4 →